325 related articles for article (PubMed ID: 27193823)
21. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.
McGary EC; Weber K; Mills L; Doucet M; Lewis V; Lev DC; Fidler IJ; Bar-Eli M
Clin Cancer Res; 2002 Nov; 8(11):3584-91. PubMed ID: 12429650
[TBL] [Abstract][Full Text] [Related]
22. PDGF-D, a new protease-activated growth factor.
LaRochelle WJ; Jeffers M; McDonald WF; Chillakuru RA; Giese NA; Lokker NA; Sullivan C; Boldog FL; Yang M; Vernet C; Burgess CE; Fernandes E; Deegler LL; Rittman B; Shimkets J; Shimkets RA; Rothberg JM; Lichenstein HS
Nat Cell Biol; 2001 May; 3(5):517-21. PubMed ID: 11331882
[TBL] [Abstract][Full Text] [Related]
23. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
Shimizu A; O'Brien KP; Sjöblom T; Pietras K; Buchdunger E; Collins VP; Heldin CH; Dumanski JP; Ostman A
Cancer Res; 1999 Aug; 59(15):3719-23. PubMed ID: 10446987
[TBL] [Abstract][Full Text] [Related]
24. PDGF BB induces VEGF secretion in ovarian cancer.
Matei D; Kelich S; Cao L; Menning N; Emerson RE; Rao J; Jeng MH; Sledge GW
Cancer Biol Ther; 2007 Dec; 6(12):1951-9. PubMed ID: 18075302
[TBL] [Abstract][Full Text] [Related]
25. Platelet-derived growth factor receptors (PDGFRs) fusion genes involvement in hematological malignancies.
Appiah-Kubi K; Lan T; Wang Y; Qian H; Wu M; Yao X; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2017 Jan; 109():20-34. PubMed ID: 28010895
[TBL] [Abstract][Full Text] [Related]
26. Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape.
Farooqi AA; Siddik ZH
Cell Biochem Funct; 2015 Jul; 33(5):257-65. PubMed ID: 26153649
[TBL] [Abstract][Full Text] [Related]
27. Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas.
Yang SY; Xu GM
J Clin Neurosci; 2001 May; 8 Suppl 1():49-53. PubMed ID: 11386826
[TBL] [Abstract][Full Text] [Related]
28. Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors.
Huang CC; Huang YF; Cao Z; Tan W; Chang HT
Anal Chem; 2005 Sep; 77(17):5735-41. PubMed ID: 16131089
[TBL] [Abstract][Full Text] [Related]
29. PDGF receptors in tumor biology: prognostic and predictive potential.
Paulsson J; Ehnman M; Östman A
Future Oncol; 2014; 10(9):1695-708. PubMed ID: 25145436
[TBL] [Abstract][Full Text] [Related]
30. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684
[TBL] [Abstract][Full Text] [Related]
31. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
32. Role of platelet-derived growth factors in physiology and medicine.
Andrae J; Gallini R; Betsholtz C
Genes Dev; 2008 May; 22(10):1276-312. PubMed ID: 18483217
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
[TBL] [Abstract][Full Text] [Related]
34. The roles of platelet-derived growth factors and their receptors in brain radiation necrosis.
Miyata T; Toho T; Nonoguchi N; Furuse M; Kuwabara H; Yoritsune E; Kawabata S; Kuroiwa T; Miyatake S
Radiat Oncol; 2014 Feb; 9():51. PubMed ID: 24512807
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
[TBL] [Abstract][Full Text] [Related]
37. PDGF-D signaling: a novel target in cancer therapy.
Wang Z; Kong D; Li Y; Sarkar FH
Curr Drug Targets; 2009 Jan; 10(1):38-41. PubMed ID: 19149534
[TBL] [Abstract][Full Text] [Related]
38. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively.
Valius M; Bazenet C; Kazlauskas A
Mol Cell Biol; 1993 Jan; 13(1):133-43. PubMed ID: 7678051
[TBL] [Abstract][Full Text] [Related]
39. Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse model.
Jain RK; Lahdenranta J; Fukumura D
PLoS Med; 2008 Jan; 5(1):e24. PubMed ID: 18232729
[TBL] [Abstract][Full Text] [Related]
40. Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis.
Cao Y
Trends Mol Med; 2013 Aug; 19(8):460-73. PubMed ID: 23773831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
